持续气道正压通气治疗与睡眠呼吸暂停患者性生活质量的相关性:一项随机临床试验的随访研究
该前瞻性队列研究纳入182例新诊断的重度阻塞性睡眠呼吸暂停患者,随访12个月,使用SNORE-25量表评估性生活质量(0-5分,分数越高越差)。结果显示,CPAP使用者的性生活质量改善优于非使用者(差异0.54,95%CI 0.18-0.90),校正混杂因素后差异仍显著(0.49,95%CI 0.09-0.89);亚组分析显示女性改善显著,男性无显著改善。
要点
- CPAP使用与性生活质量改善相关,校正后差异0.49(95%CI 0.09-0.89)。
- 女性亚组显示大幅改善(校正差异1.34,95%CI 0.50-2.18),男性无显著改善。
- 研究为前瞻性队列,需进一步研究其他性生活质量指标和治疗方法。
核心结论
- 成功的CPAP使用可能与性生活质量改善相关,女性亚组改善显著,男性无改善。
研究设计与样本
- 前瞻性队列研究,单中心三级医疗中心,纳入182例新诊断阻塞性睡眠呼吸暂停并处方CPAP的患者,随访12个月。
主要发现
- CPAP使用者(每晚平均6.4小时)较非使用者(0小时)性生活质量评分改善更大(0.7 vs 0.1;差异0.54;95%CI 0.18-0.90;效应量0.47)。
- 校正年龄、性别、种族、婚姻状况、收入、教育、BMI、AHI和功能共病指数后,调整差异为0.49(95%CI 0.09-0.89;效应量0.43)。
- 女性亚组校正差异1.34(95%CI 0.50-2.18;效应量0.87),男性亚组校正差异0.16(95%CI -0.26至0.58;效应量0.19)。
关键数值与推荐
- CPAP使用者定义为每晚使用超过4小时,非使用者定义为每晚使用少于0.5小时。
- 性生活质量域评分范围0-5分,分数越高越差。
临床怎么用
- 对于阻塞性睡眠呼吸暂停患者,尤其是女性,成功CPAP治疗可能改善性生活质量。
- 男性患者性生活质量改善不显著,需进一步评估其他干预措施。
局限性
- 研究为单中心前瞻性队列,非随机对照,可能存在残余混杂。
- 性生活质量仅通过SNORE-25量表的2个条目评估,需进一步验证其他测量工具。
- 亚组分析样本量有限,女性改善结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Obstructive sleep apnea reduces sexual quality of life (QOL) as a result of reduced libido and intimacy, erectile dysfunction, and several other mechanisms. Treatment for obstructive sleep apnea may improve sexual QOL. OBJECTIVE: To test the association of long-term continuous positive airway pressure (CPAP) treatment with sexual QOL for patients with obstructive sleep apnea. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study at a single, tertiary medical center of patients with newly diagnosed obstructive sleep apnea who were prescribed CPAP treatment from September 1, 2007, through June 30, 2010 (follow-up completed June 30, 2011). The statistical analysis was performed from February 1 through December 31, 2017. EXPOSURES: Use of CPAP treatment objectively measured by the number of hours per night. Users of CPAP were defined as patients who used CPAP treatment for more than 4 hours per night, and nonusers were defined as patients who used CPAP treatment for fewer than 0.5 hours per night. MAIN OUTCOMES AND MEASURES: Data were collected from eligible patients before CPAP treatment was prescribed and 12 months later by using the validated Symptoms of Nocturnal Obstruction and Related Events-25 (SNORE-25) QOL instrument. The 2 sex-specific items used to create the sexual QOL domain were taken from the SNORE-25. The sexual QOL domain was scored in a range from 0 to 5 (higher score is worse). The difference in sexual QOL between CPAP users and nonusers was analyzed using a paired, 2-tailed t test and multivariable linear regression adjusted for potential confounders. RESULTS: Of the 182 participants in the cohort, 115 (63.2%) were men (mean [SD] age, 47.2 [12.3] years) with severe OSA (mean [SD] apnea-hypopnea index, 32.5 [23.8] events per hour). At the 12-month follow-up, 72 CPAP users (mean [SD] use, 6.4 [1.2] hours per night) had greater improvement than 110 nonusers (0 [0] hours per night) in sexual QOL scores (0.7 [1.2] vs 0.1 [1.1]; difference, 0.54; 95% CI, 0.18-0.90; effect size, 0.47). A moderate treatment association was observed after adjustment for age, sex, race/ethnicity, marital status, income level, educational level, body mass index, apnea-hypopnea index, and the Functional Comorbidity Index (adjusted difference, 0.49; 95% CI, 0.09-0.89; effect size, 0.43). Subgroup analysis revealed a large treatment association for women (adjusted difference, 1.34; 95% CI, 0.50-2.18; effect size, 0.87) but not for men (adjusted difference, 0.16; 95% CI, -0.26 to 0.58; effect size, 0.19). CONCLUSIONS AND RELEVANCE: Successful CPAP use may be associated with improved sexual QOL. Subgroup analysis revealed a large improvement in women but no improvement in men. Further study is warranted to test other measures of sexual QOL and other treatments. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00503802.
引用
- Jara SM, Hopp ML, Weaver EM, et al. Association of Continuous Positive Airway Pressure Treatment With Sexual Quality of Life in Patients With Sleep Apnea: Follow-up Study of a Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29800001. doi:10.1001/jamaoto.2018.0485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。